Evidence map›Paper›PMID 41844694›Full record

ArticleScientific reports2026

Modified Smith predictor-based fuzzy self-tuning FOPID controller for mean arterial pressure regulation.

Hamed Khodadadi, Hamid Ghadiri, Ali Dehghani

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hamed KhodadadiDepartment of Electrical Engineering, Kho.C., Islamic Azad University, Khomeinishahr, Iran. Hamed.khodadadi@gmail.com.ORCID http://orcid.org/0000-0002-1562-3564
Hamid GhadiriDepartment of Electrical Engineering, Qa.C., Islamic Azad University, Qazvin, Iran. H.ghadirii@iau.ac.ir.
Ali DehghaniDepartment of Electrical Engineering, Kho.C., Islamic Azad University, Khomeinishahr, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The simultaneous regulation of hemodynamic variables, particularly mean arterial pressure (MAP) and cardiac output (CO), is challenging due to time-varying delays, cross-coupling effects, and parameter uncertainty inherent in drug-response dynamics. A robust control framework is developed that integrates a fractional-order PID (FOPID) controller with a fuzzy logic self-tuning mechanism (FLST) and a modified Smith predictor (MSP) to enable adaptive gain scheduling and explicit compensation of bounded delays. The patient is modeled as a two-by-two first-order time-delay MIMO system actuated by sodium nitroprusside (SNP) and dopamine (DPM). Besides, transport and recirculation delays are assumed variable and conservatively bound at 60 s. While the inclusion of fractional orders provides additional degrees of freedom, resulting in improved transient performance and enhanced steady-state accuracy, the MSP maintains stability and tracking performance in the presence of time-varying delays. Extensive simulation studies under nominal and uncertain conditions demonstrate faster rise and settling times, reduced overshoot, and lower integral error indices than those of conventional PID and fractional-order PID controllers. Robustness to inter-patient variability in the presence of disturbances and noise measurement, and clinically acceptable performance, indicating feasibility for real-time closed-loop drug infusion. Overall, the proposed FLST-FOPID-MSP architecture offers a promising and safety-oriented solution for automated MAP and CO regulation and motivates future comparisons with predictive and -based control strategies.

Indexed as

Fuzzy logic self-tuning fractional-order PID controllerMean arterial pressureMIMO time-delay systemModified Smith predictor

Identifiers

PMID41844694
PMCPMC13338428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.